PROCEPT BioRobotics
PRCT | NASDAQ
$23.54
-$0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM ET
$23.00
-$0.54 (-2.29%)
After-hours:
Nov 16, 2026, 7:30 PM ET
PROCEPT BioRobotics Company Profile
Company profile explainedCompany Profile
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Key Executives
| Name | Position |
|---|---|
| Larry L. Wood | President, Chief Executive Officer & Director |
| Alaleh Nouri | EVice President, Chief Legal Officer & Corporate Secretary |
| Barry Templin | Executive Vice President & Chief Technology Officer |
| Kevin Waters | Executive Vice President & Chief Financial Officer |
| Stacey L. Porter | Executive VP & Chief People Officer |
| Bijesh Chandran | Executive Vice President of Regulatory Affairs & Quality Assurance |
| Christofer Christoforou | Executive Vice President of Operations |
| Matthew James Bacso | Vice President of Investor Relations |
| Pooja Sharma Rao | Executive VP and Chief Strategy & Marketing Officer |
| Stephen J. McGill | Senior VP & GM of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 3 | Filing |
| Oct 02, 2026 | 8-K | Current Report |
| Sep 24, 2026 | 8-K | Current Report |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Aug 14, 2026 | 4 | Filing |
| Aug 14, 2026 | 4 | Filing |
PROCEPT BioRobotics
| Country | United States |
| IPO Date | Sep 15, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 888 |
| CEO | Larry L. Wood |
Contact Details
150 Baytech Drive San Jose,
California 95134 United States
Stock Details
| Ticker Symbol | PRCT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001588978 |
| CUSIP Number | 74276L105 |
| ISIN Number | US74276L1052 |
| SIC Code | 3841 |
Recent News
- 12 days ago / marketbeat.comPROCEPT BioRobotics Q3 Earnings Call Highlights
- 12 days ago / seekingalpha.comPROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call Transcript
- 12 days ago / zacks.comPROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates
- 20 days ago / zacks.comPROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- 25 days ago / seekingalpha.comPROCEPT BioRobotics: Compelling Bet On Aquablation's Growth
- 28 days ago / gurufocus.comPROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors
- 1 month ago / globenewswire.comPROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
- 2 months ago / globenewswire.comLAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
- 2 months ago / prnewswire.comLAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation
Add to Watchlist
Select watchlists to add or remove PRCT